期刊文献+

精神分裂症患者发生代谢综合征危险因素研究 被引量:10

The risk factors for schizophrenia patients to develop metabolic syndrome
原文传递
导出
摘要 目的探讨精神分裂症患者代谢综合征发生的危险因素。方法以是否发生代谢综合征为标准,将84例单=服用氯氮平治疗的精神分裂症患者分为两组,其中代谢综合征组36例,非代谢综合征组48例。收集患者的=般资料,包括性别,年龄,吸烟史,教育程度,婚姻状况,服药剂量,服药时间,晨起空腹状态下测定患者的体重,身高,腰围,血压,空腹血糖,总胆固醇,甘油三酯,低密度脂蛋白,高密度脂蛋白,C-反应蛋白,IL-6,比较分析两组=般资料和所测定指标的差异。结果代谢综合征组患者的吸烟率(P=0.006),腰围(P=0.001),空腹血糖(P〈0.001),甘油三酯(P=0.008),C-反应蛋白(P〈0.001)和白介素-6(P〈0.001)水平明显高于非代谢综合征组,两组间差异具有统计学意义。以是否发生代谢综合征为因变量,建立Logistic回归模型,血糖(95%CI,OR:5.5,27.03),收缩压(95%CI,0R:1.84,2.39),年龄(95%CI,OR:1.17,1.37),腰围(95%a,隙:1.83,3.07),甘油三酯(95%CI,OR:23.08,45.26),C=反应蛋白(95%CI,OR:1.08,2.94)这6个变量进入回归方程。结论发生代谢综合征的精神分裂症患者,具有更高的吸烟比率,腰围,空腹血糖,甘油三酯和C-反应蛋白水平,而空腹血糖,收缩压,年龄,腰围,甘油三酯和C-反应蛋白是代谢综合征发生的独立危险因素,可以作为预测指标,做到代谢综合征的早期预防和干预。 Objective The purpose of this study was to explore the risk factors of metabolism syndrome in schizophrenia. Methods 84 schizophrenic patients treated with clozapine were divided to two groups ,one with metabolism syndrome ( n = 36), the other without metabolism syndrome ( n = 48). The demographic data,including sex, age, smoking history, education level, marriages, dose of clozapine, duration of drug administration were collected. The body weight, height, waist circumference, fasting glucose,total cholesterol,blood pressure, triglyceride,low density lipoprotein, high density lipoprotein,C- reactive protein,interleukin 6 were measured and compared between the two groups. Results Patients with metabolism syndrome tend to have higher level of smoking rate(P = 0.006), waist circumference (P = 0. 001), fasting glucose (P 〈0. 001), serum triglyceride (P = 0. 008), C-reactive protein (P 〈 0. 001) and interleukin 6 (P〈 0. 001) than those without metabolic syndrome. The logistic analysis was performed to explore the risk factors for metabolism syndrome and the results showed that fasting glucose (95% CI OR : 5.5,27.03) ,systolic pressure( OR 95% CI .. 1.84,2.39) ,age(95%CI OR .. 1.17,1.37), waist circumference ( OR 95 % CI : 1.83 , 3.07), serum triglyceride (95 % CI OR : 23.08, 45.26),C-reactive protein( OR 95 % CI: 1.08,2.94) turned to be the independent risk factors for metabolism syndrome. Conclusions Schizophrenic patients with metabolism syndrome had higher level of smoking rate , waist circumference, fasting glucose,diastolic pressure and C-reactive protein. These parameters could be used as predictors for metabolism syndrome in schizophrenic patients, so that early clinical prevention and intervention could be performed.
出处 《神经疾病与精神卫生》 2012年第2期121-124,共4页 Journal of Neuroscience and Mental Health
基金 国家自然科学基金(81171272) 上海市精神卫生中心院级课题Shanghai Mental Health enter Research Foundation(2010-YJ-03)
关键词 精神分裂症 代谢综合征 危险因素 Schizophrenia, Metabolism syndrome, Risk factors
  • 相关文献

参考文献19

  • 1Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults., findings from the Third National Health and Nutrition Examination Survey[J]. JAMA,2002, 287(3) :356-359.
  • 2Littrell K,Perry R, Hilligoss N, et al. Insulin resistance and syndrome X among schizophrenic patients[C]. Presented at the 156th annual meeting of the American Psychiatric Associ- ation,2003:17-22.
  • 3Vanhala MJ,Kumpusalo EA,Pitkajarvi TK, et al. Metabolic syndrome in a middle-aged Finnish population[J]. J Cardio- vasc Risk, 1997,4 (4) : 291 - 295.
  • 4Reaven, GM. Syndrome X[J]. Blood Press Suppl, 1992,4: 13-16.
  • 5Sicras-Mainar A,Rejas-Guti6rrez J ,Navarro-Artieda R,et al. C-reactive protein as a marker of cardiovascular disease in patients with a schizophrenia spectrum disorder treated in rou- tine medical practice[J]. Eur Psychiatry,2011 ,Sep 30. [Epubahead of printS].
  • 6Kornegay CJ, Vasilakis- Scaramozza C, Jiek H. Incident dia- betes associated with antipsychotic use in the United Kingdom General Practice Research Database[J]. J Clin Psychiatry, 2002,63(9) :758-762.
  • 7Sernyak MJ,Leslie DL,Alareon RD,et al. Association of dia- betes mellitus with use of atypical neuroleptics in the treat- ment of schizophrenia[J]. Am J Psychiatry, 2002, 159 (4) : 651-566.
  • 8De Hert M,Vancampfort D,Correll CU,et al. Guidelines for screening and monitoring of eardiometabolie risk in schizophre- nia: systematic evaluation[J]. Br J Psychiatry,2011,199(2) : 99-105.
  • 9De Hert M,Detraux J, van Winkel R, et al. Metabolic and car- diovascular adverse effects associated with antipsychotic drugs [J]. Nat Rev Endocrinol,2011, Epub ahead of print.
  • 10Lao XQ,Jiang CQ,Zhang WS,et al. Smoking,smoking cessa- tion and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study[J].Atherosclerosis,2009, 203(1) :304-310.

同被引文献110

引证文献10

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部